Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Nutr Cancer ; 63(5): 714-21, 2011.
Article in English | MEDLINE | ID: mdl-21667399

ABSTRACT

The incidence of squamous cancer of the esophagus varies up to a hundredfold in different regions of the world. In Transkei, South Africa, a particularly high incidence of the disease is observed. We have previously proposed an association between a maize-rich diet and elevated levels of intragastric prostaglandin E2 production (PGE(2)). Here we investigate the molecular mechanisms by which a high-maize diet could lead to increased incidence of squamous cancer of the esophagus. We confirm that levels of PGE(2) are high (606.8 pg/ml) in the gastric fluid of individuals from Transkei. We also show that treatment of esophageal cells with linoleic acid, which is found at high levels in maize and is a precursor to PGE(2), leads to increased cell proliferation. Similarly, treatment of cells with PGE(2) or with gastric fluid from Transkeians also leads to increased proliferation. Our data suggest that the high levels of PGE(2) associated with a maize-rich diet stimulate cell division and induce the enzyme COX 2, resulting in a positive feedback mechanism that predisposes the esophagus to carcinoma.


Subject(s)
Carcinoma, Squamous Cell/epidemiology , Carcinoma, Squamous Cell/metabolism , Dinoprostone/metabolism , Esophageal Neoplasms/epidemiology , Esophageal Neoplasms/metabolism , Feedback, Physiological , Zea mays/adverse effects , Black People , Carcinoma, Squamous Cell/ethnology , Cell Line , Cell Proliferation , Cyclooxygenase 2/genetics , Cyclooxygenase 2/metabolism , Diet/adverse effects , Diet/ethnology , Disease Susceptibility/metabolism , Esophageal Neoplasms/ethnology , Esophagus/metabolism , Gastric Juice/metabolism , Gene Expression Regulation, Neoplastic , Humans , Linoleic Acid/analysis , Linoleic Acid/metabolism , RNA, Messenger/metabolism , Risk Factors , Seeds/adverse effects , Seeds/chemistry , South Africa/epidemiology , Surveys and Questionnaires , Zea mays/chemistry
2.
Arch Ophthalmol ; 125(4): 515-9, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17420372

ABSTRACT

OBJECTIVES: To determine the role of systemic complement activation in the pathogenesis of age-related macular degeneration and to examine whether serum C3a des Arg reflects systemic complement activation, independent of individual complement component levels. METHODS: Plasma complement C3a des Arg levels and a single nucleotide polymorphism at position 402 of the complement factor H gene (CFH) were determined in 3 groups of subjects: 42 subjects with early age-related maculopathy, 42 subjects with neovascular (wet) age-related macular degeneration, and a control group of 38 subjects with no clinical evidence of age-related changes at the macula. RESULTS: The median (range) of plasma complement C3a des Arg levels in the age-related maculopathy and neovascular age-related macular degeneration groups were 52.6 (2.8-198.1) ng/mL and 60.9 (3.1-173.1) ng/mL, respectively. The levels were significantly raised compared with the control group (n = 38), which had a median (range) plasma complement C3a des Arg level of 40.3 (6.1-81.7) ng/mL (analysis of variance, P = .02). The concentration of plasma C3a des Arg did not differ significantly between those with different CFH genotypes (P = .07). CONCLUSION: Systemic activation of the complement system may contribute to the pathogenesis of age-related macular degeneration independent of CFH polymorphism. CLINICAL RELEVANCE: The results of this study may be relevant to aiming new treatment strategies toward reducing systemic low-grade inflammation.


Subject(s)
Choroidal Neovascularization/blood , Complement Activation/physiology , Complement C3a/analysis , Macular Degeneration/blood , Choroidal Neovascularization/etiology , Choroidal Neovascularization/genetics , Complement Factor H/genetics , Enzyme-Linked Immunosorbent Assay , Genotype , Humans , Macular Degeneration/etiology , Macular Degeneration/genetics , Polymorphism, Single Nucleotide
3.
Clin Exp Ophthalmol ; 33(5): 518-23, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16181282

ABSTRACT

Several clinical and epidemiological studies have concurrently illuminated established cardiovascular risk factors in age-related macular degeneration (AMD), raising the possibility that cardiovascular disease and AMD may share a similar pathogenic process. The vascular intima and the Bruch's membrane share several age-related changes and are the seat of many common molecules. Diseases of these structures may represent parallel responses to the tissue injury induced by multiple intercalated factors such as genetic variations, oxidative stress, inappropriately directed immune response or inflammatory disease complex. However, there are marked differences in the age-related changes in these two structures. The strategic location of the Bruch's membrane between the retinal pigment epithelium and the choriocapillaris can at least partially explain the differential susceptibility of AMD to cardiovascular risk factors. Unlike the vascular wall that is exposed to changes from the endothelium, the Bruch's membrane is subject to changes from both the endothelium (choriocapillaris) and epithelium (retinal pigment epithelium). Moreover, although both the vascular wall and Bruch's membrane become lipid laden with age, the lipid composition is characteristically different. This review examines the morphological and biochemical alterations in the senescent Bruch's membrane and its analogy to the vascular wall to evaluate the concurrence of atherosclerosis and AMD.


Subject(s)
Atherosclerosis/complications , Bruch Membrane/pathology , Macular Degeneration/complications , Tunica Intima/pathology , Bruch Membrane/metabolism , Extracellular Matrix/metabolism , Humans , Matrix Metalloproteinases/metabolism , Membrane Lipids/metabolism , Tunica Intima/metabolism
4.
Invest Ophthalmol Vis Sci ; 46(9): 3046-51, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16123400

ABSTRACT

PURPOSE: Dysregulation of the extracellular matrix (ECM) plays an important role in the pathogenesis of age-related macular degeneration (AMD). Elastin is a fibrous protein constituent of the ECM, degradation of which may be detected by the presence of serum elastin-derived peptides (S-EDPs) in circulation. This study was undertaken to estimate levels of S-EDPs in patients with AMD compared with age-matched control subjects. METHODS: Fifty-six patients with AMD were classified into two groups: early age-related maculopathy (ARM) and neovascular AMD. The control group consisted of 15 age-matched subjects with no AMD. S-EDP levels in the serum of these subjects was estimated by competitive ELISA, using solubilized alpha-elastin from human aorta and polyclonal antibodies to this antigen. RESULTS: S-EDPs were significantly higher in patients with AMD than in control subjects. In addition, subjects with neovascular AMD had higher levels of S-EDPs than did those with early disease. CONCLUSIONS: The cause of this association between S-EDPs and AMD is unknown, but it suggests that systemic elastin degradation may increase the risk of conversion from early ARM to neovascular AMD. Further studies are needed to confirm whether the serum level of S-EDPs is a useful predictor of conversion from early ARM to neovascular AMD.


Subject(s)
Elastin/blood , Macular Degeneration/blood , Aged , Aged, 80 and over , Aging/physiology , Antibody Specificity , Enzyme-Linked Immunosorbent Assay , Female , Humans , Macular Degeneration/classification , Male , Middle Aged , Peptides/blood , Retinal Neovascularization/blood
5.
Invest Ophthalmol Vis Sci ; 45(5): 1281-8, 2004 May.
Article in English | MEDLINE | ID: mdl-15111578

ABSTRACT

PURPOSE: Sub-RPE deposits form in a variety of conditions most notably in age-related macular degeneration. The purpose of this study was to generate sub-RPE deposits in vitro and to test the hypotheses that high protein concentrations or retinal homogenate increase deposit formation and that a challenge with tumor necrosis factor (TNF)-alpha or metalloproteinase (MMP)-2 decreases such deposits. METHODS: ARPE-19 cells were grown on plastic and on collagen type I-coated membrane inserts in media containing various concentrations of fetal calf serum (FCS), bovine serum albumin, or porcine retinal homogenate. In addition, cells grown on membrane inserts were treated with TNF-alpha or MMP-2. Sub-RPE deposits were assessed by electron microscopy and classified into fibrillar, condensed, banded, and membranous subtypes. The area of the micrograph occupied by each type was estimated with a point-counting technique. MMP-2 activity was assessed in tissue culture supernatants by zymography. RESULTS: With increasing time in culture, total deposit formation did not change, but the amount of condensed material deposited by ARPE-19 cells increased while the fibrillar component decreased. Albumin challenge resulted in an increased amount of deposit, predominantly of the membranous type. Challenge with retinal homogenate led to a greater net deposit formation with significant increases in the condensed and banded forms. Cells treated with TNF-alpha or MMP-2 showed a dramatic reduction in all types of sub-RPE deposit. Zymography demonstrated that unchallenged cells produced predominantly MMP-2. Retinal homogenate challenge reduced the total amount of active MMP-2 produced, and TNF-alpha stimulated MMP-9 production. CONCLUSIONS: Sub-RPE deposits formed in vitro share ultrastructural features with those seen in vivo. Deposit formation can be modulated by challenge with retinal homogenate, TNF-alpha, or MMP-2. Significantly, the results provide proof of the principle that sub-RPE deposits can be formed and modified in vitro.


Subject(s)
Macular Degeneration/metabolism , Models, Biological , Pigment Epithelium of Eye/metabolism , Animals , Cells, Cultured , Humans , Macular Degeneration/etiology , Macular Degeneration/pathology , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 2/pharmacology , Matrix Metalloproteinase 9/metabolism , Pigment Epithelium of Eye/drug effects , Pigment Epithelium of Eye/ultrastructure , Retina/physiology , Serum Albumin, Bovine/physiology , Swine , Tumor Necrosis Factor-alpha/pharmacology
6.
Invest Ophthalmol Vis Sci ; 45(2): 675-84, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14744914

ABSTRACT

PURPOSE: Oxidative stress has been implicated in the pathogenesis of age-related macular degeneration. The cell line ARPE-19 was therefore examined for response to oxidative stress and its effect on stress protein induction and junctional integrity. METHODS: ARPE-19 cell viability after 1 week or 5 weeks in culture was assessed in response to different concentrations of hydrogen peroxide. The response to sublethal doses was assessed by examination of heme oxygenase (HO)-1, Hsp27 and Hsp70 by immunofluorescence and Western blot analysis. Immunofluorescence was used to investigate the localization of the junctional proteins zonula occludens (ZO)-1, occludin, and N-cadherin, and beta-catenin. Subcellular fractionation was used to assess any redistribution of beta-catenin. Monolayer integrity was examined by measurement of flux of rhodamine-conjugated dextrans from the apical to basal aspect of cells. RESULTS: ARPE-19 cells cultured for 5 weeks were less sensitive to chronic oxidative stress induced by hydrogen peroxide than those cultured for 1 week. The more differentiated ARPE-19 cells had higher steady state levels of Hsp27 and Hsp70. The response to stress also differed with time in culture. The localization of junctional proteins, which became strongly peripheral after 5 weeks in culture, became disrupted after oxidative stress, and cytosolic beta-catenin increased. Chronic oxidative stress also increased paracellular flux across the monolayer. CONCLUSIONS: Increased resistance to chronic oxidative stress with differentiation in ARPE-19 cells correlated with higher steady state levels of Hsp27 and Hsp70. Oxidative stress disrupted RPE cell junction and barrier integrity, which may contribute to the pathogenesis of diseases related to RPE through disruption of the blood-retinal barrier.


Subject(s)
Heat-Shock Proteins , Oxidative Stress , Pigment Epithelium of Eye/pathology , Tight Junctions/pathology , Blood-Retinal Barrier/drug effects , Blotting, Western , Cadherins/metabolism , Cell Differentiation/drug effects , Cell Line , Cell Survival/drug effects , Cytoskeletal Proteins/metabolism , Fluorescent Antibody Technique, Indirect , HSP27 Heat-Shock Proteins , HSP70 Heat-Shock Proteins/metabolism , Heme Oxygenase (Decyclizing)/metabolism , Heme Oxygenase-1 , Humans , Hydrogen Peroxide/toxicity , Membrane Proteins/metabolism , Molecular Chaperones , Neoplasm Proteins/metabolism , Occludin , Oxidants/toxicity , Phosphoproteins/metabolism , Pigment Epithelium of Eye/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Tight Junctions/metabolism , Trans-Activators/metabolism , Zonula Occludens-1 Protein , beta Catenin
7.
Biochem J ; 372(Pt 2): 427-33, 2003 Jun 01.
Article in English | MEDLINE | ID: mdl-12648035

ABSTRACT

Mutations in the retinitis pigmentosa protein gene RP2 account for up to 15% of X-linked retinitis pigmentosa. RP2 is a novel protein of unknown function, which is targeted to the plasma membrane by dual N-terminal acyl-modification. Dual-acylated proteins are targeted to lipid rafts, and some are subject to polarized sorting. Therefore we investigated the organization of RP2 on the plasma membrane. Endogenous RP2 protein was predominantly localized at the plasma membrane, and exogenously expressed green-fluorescent-protein-tagged protein was also targeted to the membrane in a wide range of cultured cells. High levels of endogenous RP2 protein were present in HeLa cells and in the retinal pigment epithelium-derived cell line ARPE19. A significant proportion of RP2 in cultured neuroblastoma cells was associated with detergent-resistant membranes (DRMs), but much less than other dually acylated proteins (e.g. Lyn and Fyn). In contrast, the RP2-interacting protein Arl3 (ADP-ribosylation factor-like 3) was not found to be associated with DRMs. The association of RP2 with DRMs was cholesterol-dependent. In polarized epithelial cells in culture and in vivo, RP2 was present in both the apical and basolateral domains of the plasma membrane. These data show that RP2 is not specific to either domain, unlike some other dually acylated proteins. Interestingly, the level of RP2 protein increased in the epithelial cell line Caco-2 with differentiation and polarization. These data show that RP2 is present on the membrane of all cell types examined both in vitro and in vivo, and that RP2 associates with lipid rafts, suggesting a potential role for the protein in signal transduction.


Subject(s)
Cell Membrane/metabolism , Eye Proteins , Proteins/metabolism , Acylation , Animals , Cell Differentiation , Cells, Cultured/metabolism , GTP-Binding Proteins , Green Fluorescent Proteins , HeLa Cells , Humans , Immunoenzyme Techniques , Intracellular Signaling Peptides and Proteins , Luminescent Proteins/metabolism , Membrane Proteins , Microscopy, Confocal , Pigment Epithelium of Eye/metabolism , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL
...